Paratek Pharmaceuticals, Inc.
9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (CABP)
Last updated:
Abstract:
The invention disclosed herein provides a method for treating Community-Acquired Bacterial Pneumonia (CABP) using 9-[(2,2-dimethyl-propyl amino)-methyl]-minocycline or a salt thereof, in either oral or IV doses or a combination of both.
Status:
Grant
Type:
Utility
Filling date:
10 Jul 2019
Issue date:
17 Nov 2020